Bafucin mint lozenges

Bafucin is a well-known medicinal throat lozenge brand primarily marketed in the Nordic regions, particularly Sweden. It is used to treat sore throats and mild infections of the oral cavity due to its combination of local anesthetic and antibacterial properties.

The brand has a long history under various pharmaceutical giants. Originally associated with AstraZeneca, the brand was part of a larger divestment of over-the-counter (OTC) products. In 2020, Karo Healthcare (formerly Karo Pharma) acquired a portfolio of brands, including Bafucin, from Teva Pharmaceuticals. Today, the brand is managed by Karo Healthcare, a company headquartered in Stockholm, Sweden, which specializes in everyday healthcare products and is owned by the private equity firm EQT.

Manufacturing of Bafucin occurs at specialized pharmaceutical facilities across Europe. While the brand is quintessentially Swedish in its market presence, the physical production is often outsourced to contract manufacturers within the European Union to ensure compliance with medical standards.